An American study shows that taking hormone replacement therapy for one year after menopause helps prevent depression.
Hot flashes, tiredness, pain ... Menopause often brings a lot of inconvenience. In many cases, it even causes depressive syndromes. A placebo-controlled study, published in the Journal of the American Medical Association's Internal Medicine version, shows that taking hormone replacement therapy for one year limits the risk of developing depression in postmenopausal women.
So far research has shown that taking hormone therapy can reduce the intensity of symptoms of depression in postmenopausal women. This new study conducted at the University of North Carolina shows that this type of treatment can prevent the onset of these symptoms for women who are in transition to menopause, or just menopausal.
A study against placebo
172 women participated in the study. Aged 45 to 60, none of them was depressed. They were followed between 2010 and 2016. Some of them received cutaneous patches with estradiol, a form of estrogen. In addition, physicians administered oral progesterone once every three months. The other half of the group received only placebos. The treatment was followed for one year.
Women who took hormone replacement therapy were less likely to develop depressive symptoms compared to those who took only placebo.
One year of treatment only
Hormone replacement therapy for menopause has been the subject of much criticism. Broadly based criticisms when these treatments are prolonged and they increase the risk of breast cancer or ovaries, but perhaps also cardiovascular problems. However, in the absence of a contraindication, hormone replacement therapy, especially when it consists of natural hormones, is an excellent treatment for menopausal disorders and therefore depressive syndrome occurring in these circumstances.
In all cases, taking hormonal treatment should be discussed with the doctor.